MR-proANP (Mid-Regional Pro-Atrial Natriuretic Peptide) and MR-proADM (Mid-Regional Pro-Adrenomedullin) can be used in parallel under heart failure conditions, as these markers are more reliable during acute episodes, offering moderate sensitivity and high specificity [53,54]. Here, NPPA is linked to heart failure.